statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the...

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference

For the last three days, A.I.dvisor has detected that PCVX's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...

Vaxcyte (PCVX, $66.69) Aroon Indicator entered a Downtrend on April 01, 2024.

Shares of Vaxcyte, Inc. (NASDAQ:PCVX - Get Free Report) have received an average recommendation of "Buy" from the five brokerages that are currently covering the stock, Marketbeat.com reports. Five...

Analysts Set Vaxcyte, Inc. (NASDAQ:PCVX) Target Price at $78.50

Vaxcyte (PCVX, $68.23) Aroon Indicator entered a Downtrend on March 28, 2024.

Vaxcyte (PCVX, $68.58) Aroon Indicator entered a Downtrend on March 27, 2024.

Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares

Citigroup Inc. raised its holdings in Vaxcyte, Inc. (NASDAQ:PCVX  Free Report) by 21.4% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The...

Vaxcyte, Inc. (NASDAQ:PCVX) Shares Bought by Citigroup Inc.

Wellington Management Group LLP grew its holdings in shares of Vaxcyte, Inc. (NASDAQ:PCVX  Free Report) by 3.8% during the third quarter, according to its most recent 13F filing with the SEC...

Wellington Management Group LLP Acquires 167,501 Shares of Vaxcyte, Inc. (NASDAQ:PCVX)

Vaxcyte, Inc. (NASDAQ:PCVX  Get Free Report) was the recipient of a significant drop in short interest during the month of February. As of February 29th, there was short interest totalling...

Vaxcyte, Inc. (NASDAQ:PCVX) Sees Large Decline in Short Interest

Shares of Vaxcyte, Inc. (NASDAQ:PCVX  Get Free Report) have received an average recommendation of Buy from the five ratings firms that are currently covering the stock...

Vaxcyte, Inc. (NASDAQ:PCVX) Given Average Rating of "Buy" by Brokerages

Vaxcyte, Inc. engages in the development of vaccines for infectious diseases. It focuses on conjugate vaccines and protein-based vaccines developed through the Sutro Biopharma's Xpress CF Platform, a cell-free protein synthesis technology. The company was founded by Grant E. Pickering and Jeff Fairman on November 27, 2013, and is headquartered in San Carlos, CA.

Volume	101,296.00
52-Wk High	$82.04
52-Wk Low	$44.20

Period	Estimated	Reported	Surprise	Result
Q1'24	-$1.13	--	--	N/A
Q4'23	-$1.05	-$1.83	-73.55%	MISSED
Q3'23	-$0.84	-$0.91	-8.64%	MISSED
Q2'23	-$0.75	-$0.70	6.04%	BEAT
Q1'23	-$0.82	-$0.70	14.85%	BEAT

PCVX Vaxcyte Inc

About

Feed

News

Sentiment

Earnings

Fundamentals